[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620861":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":15,"collaborators":10,"id":19,"slug":20,"hasResults":21,"nctId":22,"briefTitle":23,"officialTitle":24,"acronym":10,"eligibilityCriteria":25,"healthyVolunteers":26,"sex":27,"minAge":28,"maxAge":29,"enrollmentInfo":30,"targetDuration":10,"studyType":33,"phases":10,"briefSummary":34,"conditions":35,"keywords":39,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"T2DM Patients",null,"100 adults aged 30-70 years diagnosed with type 2 diabetes mellitus (T2DM) for ≥1 year (fasting glucose ≥126 mg\u002FdL or HbA1c ≥6.5%), assessed for platelet indices (MPV, PDW, etc.), inflammatory markers (hs-CRP, ESR), and glycemic parameters via single blood draw and clinical evaluation; exclusions include type 1 DM, infections, anti-platelet drugs.",{"label":13,"type":10,"description":14,"interventionNames":10},"Healthy Controls","100 healthy adults aged 30-70 years without diabetes or major systemic illness, evaluated similarly for platelet indices, inflammatory markers, and basic glycemic parameters as comparators in this cross-sectional case-control study at Assiut University Hospitals.",{"type":16,"investigatorFullName":17,"investigatorTitle":18,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Hagar Hassan Mostafa Ahmed","Resident at Clinical Pathology Department, Assiut University","100620861","platelet-changes-in-type-2-diabetes-100620861",false,"NCT07363122","Platelet Changes in Type 2 Diabetes","Platelet Indices Changes in Type 2 Diabetes Mellitus and Their Relationship With Inflammatory Markers","Inclusion Criteria:\n\n* Adults aged 30-70 years.\n* Diagnosed T2DM for at least 1 year.\n* Fasting blood glucose ≥126 mg\u002FdL and\u002For HbA1c ≥ 6.5%\n\nExclusion Criteria:\n\n* Type 1 Diabetes Mellitus\n* Acute infection, chronic inflammatory disease\n* Malignancy.\n* Current use of anti-platelet or anti-inflammatory medications\n* Chronic liver, renal, or hematologic disease\n* Recent major surgery or trauma (within 3 months)",true,"ALL","30 Years","70 Years",{"count":31,"type":32},200,"ESTIMATED","OBSERVATIONAL","This study examines changes in platelet indices in people with type 2 diabetes compared to healthy people. It checks if these changes relate to inflammation markers (like hs-CRP) and blood sugar control. Participants get routine blood tests during one clinic visit at Assiut University Hospitals. No treatments or extra procedures are involved.",[36,37,38],"Platelet Indices","Type 2 Diabetes","Inflammatory Markers",[40,41,42,43,44],"Platelets","Platelet indices","T2DM","Type 2 Diabetes Mellitus","inflammatory markers","NOT_YET_RECRUITING","2026-01-15",{"date":48,"type":49},"2026-01-23","ACTUAL",{"date":51,"type":32},"2026-02",{"date":53,"type":32},"2027-03",{"name":5,"class":6}]